Is Dietary Intervention a Viable Method for Improving Outcomes in Adult Patients with Asthma? by Grolimund, Jennifer
Running head: DIET AND ASTHMA                                                                   1 
 
 
 
 
 
 
 
 
Is Dietary Intervention a Viable Method  
for Improving Outcomes in Adult Patients with Asthma? 
 
 
 
 
 
 
 
 
 
 
Jennifer Grolimund 
 
 
 
 
 
 
 
 
 
 
 
 
A Senior Thesis submitted in partial fulfillment 
of the requirements for graduation 
in the Honors Program 
Liberty University 
Spring 2016 
  
DIET AND ASTHMA  2 
 
 
Acceptance of Senior Honors Thesis 
 
This Senior Honors Thesis is accepted in partial 
fulfillment of the requirements for graduation from the 
Honors Program of Liberty University. 
 
 
      
  
______________________________ 
Cynthia Goodrich, Ed.D., M.S.N., RN, CNE 
Thesis Chair 
 
 
         
______________________________ 
Chad Magnuson, Ph.D. 
Committee Member 
 
 
      
 
______________________________ 
Lucinda Drohn, M.S.N., RN 
Committee Member 
 
 
             
______________________________ 
James H. Nutter, D.A. 
Honors Director 
 
 
     
______________________________ 
Date 
  
DIET AND ASTHMA  3 
Abstract 
Asthma is a disease process characterized by episodic inflammation of the lower airway 
in response to various triggers. Those with asthma have trouble breathing effectively 
during an acute episode, making asthma a potentially life threatening condition. Standard 
medical treatment of asthma, including medications and environmental changes, can be 
effective at reducing or eliminating negative outcomes in patients with asthma. However, 
a holistic approach to patient care, including an examination of dietary influence, may 
also be useful for patients trying to manage the course of their illness. Variations in intake 
of individual nutrients or in total dietary patterns may play a role in how people with 
asthma experience symptoms. Two issues that need to be addressed regarding dietary 
intervention as a component of asthma management are (a) identifying what dietary 
elements are effective at improving asthma management; (b) implementing interventions 
that will facilitate appropriate dietary changes in an adult asthmatic patient population.  
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Is Dietary Intervention a Viable Method  
for Improving Outcomes in Adult Patients with Asthma? 
Overview of Asthma 
 Asthma is a disease process characterized by episodic inflammation and 
narrowing of the lower airway in structures called bronchioles. This process limits 
movement of air in and out of the lungs and makes effective breathing difficult for those 
experiencing symptoms. Episodes of asthma, also called asthma attacks, can be life 
threatening and may be triggered by a variety of environmental, physiological, and 
psychological factors. These factors can include, but are not limited to: allergies, air 
quality, environmental temperature, physical stress, and emotional stress. While standard 
medical treatment of asthma can be effective at stabilizing critical symptoms and 
reducing or eliminating negative outcomes for those with asthma, a holistic approach to 
patient care, including an examination of dietary influence, may also be beneficial in 
achieving positive patient outcomes (Chih-HungGuo, Po-Jen, Kuan-Pin, & Pei-Chung, 
2012; Garcia-Larsen et al., 2011; Kligler et al., 2011; McKeever et al., 2010; Roberston-
Malt, 2010; Sexton et al., 2013). If dietary intervention is to become a well-established 
component of asthma management, key issues that need to be addressed include (a) 
identifying what dietary elements are effective at improving asthma management; (b) 
implementing interventions that will facilitate appropriate dietary changes in an adult 
asthmatic patient population. 
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Impact of Nutrition 
 Two areas of interest in relation to dietary research are the influence of individual 
nutrients and the influence of total dietary patterns on respiratory health in patients with 
asthma. Studies have been conducted on polyunsaturated fatty acids (PUFAs), vitamins, 
carotenoids, and antioxidants in order to evaluate specific effects on asthma (Barros et al., 
2011; di Giuseppe, 2012; Schöttker et al., 2013; Thyagarajan et al., 2011; Wood et al., 
2012; Yang, Xun, & He, 2013). Omega-3 (n-3) PUFA is generally associated with a 
decrease in inflammation, but intervention studies have produced inconclusive results as 
to the efficacy of dietary n-3 PUFA in improving outcomes for patients with asthma. A 
low ratio of omega-6 (n-6) PUFA to n-3 PUFA, which is not found in the typical Western 
diet of processed foods, may improve asthma control, though studies surrounding this 
nutritional influence on asthma are also inconclusive (Barros et al., 2011; Yang et al., 
2013).  
Polyunsaturated Fatty Acids 
 Fatty acids, including n-6 PUFAs, n-3 PUFAs, and saturated fatty acids (SFAs) 
are involved in the metabolism, structure, and function of cells in the human body and are 
essential to several key processes in the body. SFAs like lauric acid contribute to cellular 
processes that promote inflammation. N-6 and n-3 PUFAs are also important in 
regulation of inflammation in the body. N-6 PUFAs, including arachidonic acid, are used 
in production of pro-inflammatory mediators like prostaglandins, thromboxanes, and 
leukotrienes. N-3 PUFAs, chiefly eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA), are used in production of anti-inflammatory mediators or pro-inflammatory 
mediators that are less potent than those produced with omega-6 PUFAs. EPA in 
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particular uses cyclooxygenase and 5-lipooxygenase pathways, the same chemical 
pathways as arachidonic acid, thus competing with the n-6 PUFA for the same resources 
and decreasing the amount of pro-inflammatory mediators that can be produced from 
arachidonic acid (Calder, 2012; Fetterman & Zdanowicz, 2009). 
 Both n-3 and n-6 PUFAs are normal components of certain cell membranes. 
Usually, the concentration of n-6 PUFAs in the cell membranes is higher than the 
concentration of n-3 PUFAs. However, numerous studies identified by Calder (2012) 
show that increasing dietary intake of EPA and DHA, n-3 PUFAs, leads to dose 
dependent, gradual increases in n-3 PUFA concentrations in the cells over a period of 
days to weeks. These increases in n-3 PUFA concentration also correspond with a 
decrease in arachidonic acid availability. Since n-6 PUFAs contribute to producing 
stronger pro-inflammatory mediators than n-3 PUFA produces, this shift in 
concentrations decreased the availability of components conducive to inflammation. The 
net effect of this shift is that the body produces a more moderate inflammatory response 
after supplementation with n-3 PUFAs (Calder, 2012).  
Although studies are still inconsistent as to how much these cellular changes 
translate into mediating symptom severity and incidence, shifts in PUFA concentrations 
from dietary supplementation may be beneficial in diseases with excessive inflammatory 
response as a component. As previously noted, asthma is one of these diseases. Multiple 
published reviews of research literature show that consistent supplementation with n-3 
PUFAs, EPA and DHA, over time may help improve symptoms and over lung function in 
people with asthma by altering the inflammatory response (Calder, 2012; Fetterman & 
Zdanowicz, 2009). 
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 The pathophysiology of asthma is characterized by airway hyper-reactivity, 
bronchoconstriction, and airway edema. In other words, the lungs of asthmatic patients 
are easily irritated and prone to a level of inflammation that exceeds what is beneficial for 
maintaining a healthy airway. When inflammation is triggered, the asthmatic airway 
becomes smaller and starts to accumulate fluid, increasing the work of breathing and 
potentially occluding the airway to the point where the asthmatic patient cannot breathe 
at all. The inflammatory process of asthma starts with increased involvement of 
interleukin-4, immunoglobulin E, and mast cells; then as inflammatory mediators are 
produced, blood vessels dilate and allow various cells and mediators into the area of 
inflammation, leading to bronchoconstriction and mucus accumulation (Kaufman, 2014). 
The main idea behind supplementation with fatty acids in asthmatic patients is that the 
shift in production of inflammatory substances, including interleukins, will limit the 
severity of the inflammatory response and help asthmatic patients to regain some control 
over their condition and have improved quality of life (Calder, 2012; Fetterman & 
Zdanowicz, 2009; Kaufman, 2014; Kitz et al., 2010; Kligler et al., 2011). 
 One study in 2010 focused on how concentrations of PUFAs in the body 
correlated with the response of adult asthmatic participants to a known allergen, grass 
pollen. This study found that participants with asthma generally had significantly lower 
ratios of n-3:n-6 PUFAs in their bodies compared to the healthy control group. There was 
also a strong positive correlation between low n-3:n-6 PUFA ratio and stronger 
inflammatory response in asthmatic participants, as shown by bronchial constriction. 
Participants with high levels of n-3 PUFA relative to n-6 PUFA had less severe responses 
to a known asthma trigger than participants with low n-3 PUFA. This study concluded 
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that n-3 PUFA was beneficial for the participants of this study and suggested that other 
people with asthma might benefit from increasing n-3 PUFA dietary intake, although the 
small sample size and the inclusion of only one phenotype of asthma limits how much 
these results can be generalized to the larger population of people with asthma. Another 
limitation is that the design of this study can only result in identifying correlations, not 
causation (Kitz et al., 2010).  
 Another study in 2011 examined lung function, asthma control, and dietary intake 
of fatty acids in 174 people with asthma, looking for any significant causal or 
correlational relationship between dietary fatty acids and asthma. This study found that 
participants with more asthma control tended to have lower n-6:n-3 ratios than 
participants with poor asthma control. The results of this study also showed a positive 
correlation between high asthma control and high concentrations of n-3, alpha-linoleic 
acid (ALA), EPA, DHA from dietary intake. Researchers concluded that diets high in n-3 
PUFAs might improve patient chances of having good asthma control and reduction in 
symptoms. However, the small sample size and convenience sampling method limit the 
generalizability of this study, and the lack of an intervention or control group means that 
the results cannot prove a cause-effect relationship between dietary fatty acids and 
asthma control (Barros et al., 2011). 
Some studies assess impact of dietary fatty acids by incorporating n-3 PUFA 
supplementation into more comprehensive interventions, making it difficult to link health 
benefits directly to the effects of n-3 PUFA. One such study by Kligler et al. (2011) 
tested the effectiveness of adding multiple complementary therapies to asthma patients 
receiving standard medical management for their condition. Participants in the control 
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group received only the standard medical treatment of asthma, while participants in the 
intervention group received various complementary therapies in addition to the standard 
medical treatment. Among these interventions was regular supplementation of fish oil, a 
substance high in n-3 PUFAs EPA and DHAs. This study also included group sessions of 
yoga, journaling, dietary counseling, and supplements of vitamin C and hops extract. The 
study lasted for 6 months and showed improved quality of life and reduced symptom 
incidences as reported by the participants; however, there was no significant change in 
lung function as measured by spirometry, forced vital capacity (FVC), or forced 
expiratory volume in the first second (FEV1). While this study demonstrated some level 
of effectiveness of group-oriented holistic care programs for patients with asthma, the 
results were inconclusive as to the asthma-related health benefits of dietary n-3 PUFA 
supplementation (Kligler et al., 2011). Another study focused only on dietary 
supplementation, but included vitamin A, vitamin C, vitamin E, various antioxidants, 
zinc, selenium, and calcium in addition to supplementation with fish oil. Patients in this 
two-month study had significant improvement in asthma control and statistically 
insignificant improvement in lung function tests, but specific benefits could not be linked 
directly to fish oil supplementation (Chih-HungGuo et al., 2012). 
 Systematic reviews showing inconsistent results across studies. In general, 
research literature pertaining to fatty acids and asthma frequently indicates that n-3 
PUFAs might be beneficial in asthma, but fails to show consistent results that suggest a 
measurable impact of dietary n-3 PUFA on adult asthma patients. A systematic review 
and meta-analysis done by Yang et al. (2013) analyzed 11 prospective cohort studies and 
4 randomized control trials pertaining to asthma and dietary intake of fish oil. Several of 
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the studies considered in this review process were not included in the final analysis 
because of flaws in how they reported their data, and some of the randomized control 
trials that were included had small sample sizes that make generalizing results difficult. 
The finished review indicated that intake of fish oil may be beneficial for reducing the 
risk of getting asthma in children, but that no reliable conclusions could be drawn from 
the research pertaining to adults (Yang et al., 2013).  
 An overview of 23 Cochrane meta-analyses looking at the effectiveness of 
various complementary therapies, including dietary supplementation with n-3 PUFAs, 
also concluded that available research fails to establish consistent, reliable, and 
generalizable data about dietary n-3 PFUAs and asthma. This overview identified that 
small sample sizes, flawed research designs, and inadequate reporting of study results are 
prevalent in the research literature on these therapies. These research issues limit the 
medical professional’s ability to draw up clinical guidelines and implement potentially 
helpful therapeutic interventions, despite pervasive hints at the potential effectiveness of 
these therapies in asthmatic patients (Roberston-Malt, 2010).  
Possible causes of inconsistent results and areas for further research. In addition 
to small study sample sizes and problems with reporting data, other potential reasons for 
inconsistent results with PUFA supplementation on adult asthmatic patients might be tied 
to different methods of assessing dietary intake and response to intervention. Some 
studies use food frequency questionnaires and similar participant reported measures of 
dietary intake, while other studies analyze blood samples to determine concentrations of 
different diet-derived substances in the body (Barros et al., 2011; Kitz et al., 2010). 
Studies can also use a wide variety of methods to measure asthma control, lung function, 
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and symptom response to intervention, potentially making comparison between studies 
difficult. Questionnaires rely on patients’ perceptions of symptoms, but studies can also 
include tests like exhaled nitric oxide, FVC, FEV1, spirometry, peak flow meter, or 
metacholine levels to help determine the overall picture of an asthmatic patient’s 
condition (Barros et al., 2011; Kitz et al., 2010; Kligler et al., 2011).  
Other considerations that warrant further research and may account for inconclusive 
results in the literature include: variations in supplement quality, duration, and dosage 
levels, and genetic or physiologic variations in asthma presentation causing differences in 
response to nutritional intervention (Barros et al., 2011; Calder, 2012; Fetterman & 
Zdanowicz, 2009; Kitz et al., 2010; Mickleborough & Lindley, 2013; Wendell, Baffi, & 
Holguin, 2014). The last consideration is especially interesting, as further research into 
asthma phenotypes and polymorphisms might allow clinicians to tailor dietary 
supplements to specific patients based on genetics and the etiology of a patient’s 
condition (Fetterman & Zdanowicz, 2009; Mickleborough & Lindley, 2013; Wendell et 
al., 2014).  
 The literature review conducted by Mickleborough and Lindley (2013) looked at 
the effectiveness of different dosage schedules and concentrations for n-3 PUFA 
supplementation as utilized in some studies. For dosages of fish oil, this review identified 
that supplementation with 3.2 g EPA and 2.2 g DHA daily for three weeks decreased pro-
inflammatory mediators in one study of asthmatic participants, and that some other 
studies suggest similar dosages might compare with the asthma drug Montelukast in 
mediating inflammation and bronchoconstriction long-term (Mickleborough & Lindley, 
2013), although not every study shows favorable results for short term supplementation 
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with EPA and DHA (Brannan et al., 2015). The Mickleborough and Lindley review also 
identified studies where smaller doses of EPA and DHA, anywhere from 120 mg to 1 
gram daily, were effective at improving FEV1 in small amounts if taken consistently for 
10-12 months (Mickleborough & Lindley, 2013). With such a wide range of potentially 
effective doses, this review suggested that n-3 PUFA supplementation might be most 
effective if the dose is tailored to specific patient response (Mickleborough & Lindley, 
2013).  
Tailoring n-3 PUFA doses might be easier with further research into asthma 
phenotypes and polymorphisms, which various reviews identify as possible reasons for 
varied participant responses to n-3 PUFA supplementation. A phenotype is an observable 
characteristic in the body, and in asthma the term is used to differentiate between the 
variations of triggers. For example, exercise-induced asthma would be a different 
phenotype than allergy-induced asthma. A polymorphism is a common genetic variation, 
and some asthma research suggests that responses to dietary intake of fatty acids may be 
influenced by polymorphisms in the 5-lipoxygenase pathway, which takes arachidonic 
acid or n-3 PUFAs and produces inflammatory mediators (Calder, 2012; Fetterman & 
Zdanowicz, 2009; Mickleborough & Lindley, 2013; Wendell et al., 2014).  
Further research into the effectiveness of dietary fatty acid supplementation, 
including how genetics and phenotypes impact asthma response to n-3 PUFAs, might 
allow for clinicians to eventually develop standards of practice for inclusion of n-3 PUFA 
as a supplement to current asthma treatment methods. Until that time comes, however, 
the specific benefits of implementing dietary changes with n-3 PUFAs are unclear for an 
adult asthmatic patient population. Patient decisions regarding n-3 PUFA 
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supplementation should be made in light of this uncertainty, noting that the main adverse 
effects of fish oil, a widely used n-3 PUFA supplement, are only a slight fishy aftertaste 
and the possibility of mild gastrointestinal upset (Fetterman & Zdanowicz, 2009; 
Mickleborough & Lindley, 2013; Roberston-Malt, 2010). 
Vitamin D 
Vitamin D is a fat-soluble vitamin that has a known role in regulating bone health 
and the levels of calcium and phosphorus in the body. There are two types of this vitamin 
and two ways to increase vitamin D levels in the body. Vitamin D2, also known as 
ergocalciferol, is taken from the diet. Vitamin D3, also known as cholecalciferol, is 
produced within the body when skin is exposed to sunlight (Lehne, 2012a; Lehne 2012b). 
 Although vitamin D is usually associated with bone health, it may also influence a 
variety of other body systems, including the respiratory system. One extensive 
longitudinal study in Germany showed an inverse correlation between levels of vitamin D 
and risk of mortality related to general health and to cardiovascular, cancer, and 
respiratory disorders. Participants with low levels of vitamin D tended to have a greater 
risk of mortality in all disease categories. This study defined vitamin D deficiency as < 
30 nmol/L and vitamin D insufficiency as between 30 and 50 nmol/L (ng/mL), and 
suggested that vitamin D levels > 75 nmol/L might decrease overall risk of death 
(Schöttker et al., 2013). In addition to those results, a 2013 cross-sectional study done by 
Khan, Xiao-Mei, and Yue found that low levels of vitamin D were associated with 
decreased FEV1 and FVC values in overweight and obese participants. While these two 
studies are not directly tied to asthma, they support the idea that adequate amounts of 
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vitamin D may have some protective effect on respiratory health (Khan et al., 2013; 
Schöttker et al., 2013).  
  The specifics of how and whether vitamin D concentrations in the body impact 
people with asthma is still largely unclear. There is not a great deal of research looking 
into this possible relationship. The research that does exist is inconclusive as to how 
much dietary supplementation with vitamin D might aid asthma patients, although there 
is evidence to suggest this might be possible. One cross-sectional study done in 2011 
looked at blood levels of vitamin D and lung function in 435 Chinese adults who had 
recently received a diagnosis of asthma. Over 80% of the participants had vitamin D 
deficiency of <50 nmol/L (ng/mL). There was no control group to compare results to 
non-asthmatic patients and the study only assessed existing status of the participants, 
instead of implementing an intervention to test participant response to vitamin D. Despite 
these limitations, however, this study found a strong positive correlation between vitamin 
D levels and lung function, as measured by FEV1 and FVC (Li et al., 2011). 
  The results of other, smaller cross-sectional studies done between 2010 and 2013 
are consistent with this picture of vitamin D levels and asthma. A 2010 study looked at 
vitamin D levels, airway hyper-reactivity, and patient response to corticosteroids for 
treatment of asthma. This study identified a strong association between vitamin D less 
than 30 ng/mL (nmol/L) and increased airway hyper-reactivity in response to inhaled 
methacholine challenge. This study also found an association between low vitamin D 
levels and a decrease in effectiveness of glucocorticoids used in the treatment of asthma 
(Sutherland, Goleva, Jackson, Stevens, & Leung, 2010). A 2013 study found similar 
associations between inadequate vitamin D levels and poor asthma control, although it 
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did not examine response to asthma medications (Korn, Hübner, Jung, Blettner, & Buhl, 
2013). While these cross-sectional studies provide a rationale for potential effectiveness 
of vitamin D supplementation, experimental studies are needed to establish a cause-effect 
relationship (Korn et al., 2013; Li et al., 2011; Sutherland et al., 2010).  
 One randomized control study performed in 2014 aimed to identify how vitamin 
D supplementation compared to placebo-administration in improving the effectiveness of 
corticosteroid therapy for adult asthma patients. The researchers hypothesized that 
vitamin D supplementation might improve participants’ asthma control. The primary 
focus of the study was looking at time until the first failure of treatment, defined as an 
exacerbation of asthma resulting in a need for increased medication. The results showed 
no difference in this measurement between the group that received vitamin D 
supplements and the group that received the placebo. This study did find that the group 
with vitamin D supplementation had a small but statistically significant drop in the 
corticosteroid doses necessary for maintaining lung function and asthma control, with a 
difference of roughly 15 µg/d between the final required dose of the intervention group 
and the placebo group; however, further research is necessary before clinical 
recommendations can be made for vitamin D supplementation as a component of asthma 
management (Castro et al., 2014). 
 Other areas where further research can be directed include how genetic factors of 
vitamin D absorption, metabolism, and function in the body might influence the risk for 
developing asthma or experiencing poor symptom control. Polymorphic variations in the 
genes that influence vitamin D levels might partly explain how different people or people 
groups can experience varied asthma outcomes and treatment responses. One genetic 
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analysis of 207 participants from the Chinese Hans ethnic population looked at two 
polymorphisms of the vitamin D receptor gene. This study found no significant 
association between the genetic variations and the risk for developing asthma (Fang et al., 
2009). Another genetic analysis, this time done with 1,064 French-Canadian participants, 
looked at 11 genes and 87 single-nucleotide-polymorphisms related to vitamin D in the 
body. This study found that variations in the IL10, CYP24A1, CYP2R1, ILIRL1, and 
CD86 genes had a small association with increased incidence of atopic diseases, 
including asthma (Bossé et al., 2009).  
 Overall, the effectiveness of vitamin D supplementation as a complementary 
therapy for asthma control is still unclear. There may be beneficial respiratory effects of 
maintaining adequate amounts of vitamin D, and not having enough vitamin D from diet 
or sunlight exposure might have detrimental effects on respiratory health, including in 
asthma. However, current research literature is mainly focused on correlational studies, 
and studies trying to establish causal relationships between vitamin D levels and asthma 
are inconclusive. Research into how polymorphisms might influence vitamin D levels 
and asthma is promising, but at this point in time, no clear recommendations can be made 
for incorporating vitamin D nutritional supplementation into a treatment regimen for 
people with asthma. Maintaining adequate vitamin D levels, however, would not be 
detrimental to health (Bossé et al., 2009; Castro et al., 2014; Khan et al., 2013; Korn et 
al., 2013; Li et al., 2011; Schöttker et al., 2013; Sutherland et al., 2010).  
Antioxidants    
 Carotenoids, including beta-cryptoxanthin, alpha-carotene, beta-carotene, lutein, 
and lycopene, are dietary components that have antioxidant properties and may be 
DIET AND ASTHMA  17 
beneficial for respiratory health. These nutrients can be found in vegetables and fruits, 
particularly carrots and tomatoes. In 2011, a prospective cohort study by Thyagarajan et 
al. aimed to examine a possible association between serum carotenoids and lung function 
changes, with the hypothesis that participants with high serum carotenoid concentrations 
would tend to show greater peak and slower decline in lung function over the 20-year 
study compared to participants with low serum carotenoid concentrations. The 
participants, 2,701 in total, were between the ages of 18 and 30 years. Results showed a 
significant positive correlation between initial high levels of alpha-carotene, beta-
carotene, and beta-cryptoxanthin and greater peak lung function. This study also found a 
significant inverse association between alpha-carotene, beta-carotene, beta-cryptoxanthin, 
and lutein levels and rate of lung function decline, and specifically found that a dietary 
increase in these carotenoids over 15 years had a significant positive correlation with 
slower declines in lung function (Thyagarajan et al., 2011). 
A limitation to this study by Thyagarajan et al. (2011) is that causal relationships 
between carotenoid intake and lung function cannot be established in a longitudinal 
cohort study, so only correlation can be established between the different factors. Another 
problem identified in this study is that variations in participant metabolism of the 
carotenoids might cause variations in the association of carotenoids with lung function. 
The variability of carotenoid metabolism may limit the development of generalizable 
dietary recommendations for asthma therapy, though carotenoids may be considered for 
inclusion in broader dietary interventions. Further research into carotenoids and lung 
function is needed to establish possible causal relationships and clear clinical guidelines 
(Thyagarajan et al., 2011).  
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 Total antioxidant intake is another dietary factor that may be beneficial for 
maintaining or improving respiratory health. Although the study by Thyagarajan et al. 
(2011) examined one subset of antioxidants, the carotenoids, studies looking at overall 
antioxidant intake address how the various antioxidants might interact with each other to 
create a total effect on respiratory health. In 2012, di Giuseppe et al. observed significant 
benefits of high total antioxidant intake on lung function. By analyzing the dietary intake 
and respiratory values of 11,672 participants over a period of 4 years, this study found a 
significant positive correlation between high antioxidant intake and good lung function. 
However, the correlation was only statistically significant in participants who were 
premenopausal women with no smoking history, possibly because this subset of the 
participant population experienced the least oxidative stress. This study could not 
establish causality, only correlation between the factors studied (di Giuseppe et al., 2012).  
A randomized-controlled trial by Wood et al. (2012) found that participants 
assigned to a diet high in antioxidants achieved higher FEV, greater vital capacity, and 
reduced incidence of asthma symptom exacerbation than participants assigned to a diet 
low in antioxidants. This study included 137 asthmatic adults and lasted for 14 days. 
Although the small number of participants limits the generalizability of the results, this 
study suggests that eating a diet rich in antioxidants can improve symptom severity and 
management in patients with asthma. This study also compared the effects of an 
antioxidants supplement to the effects of a placebo in the control group, and found that 
there was no significant difference between the two interventions. Beneficial effects on 
asthma were only seen in participants assigned to the high antioxidant diet, which 
included whole foods rather than supplements (Wood et al., 2012). Although research by 
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Chih-HungGuo et al. (2012) shows that nutritional supplements may improve asthma 
control and quality of life, the Wood et al. (2012) study suggests that altering the diet to 
include lots of fruits and vegetables is more effective at achieving positive patient 
outcomes in adult asthmatics than adding nutritional supplements to normal dietary 
intake patterns.  
Nutritional Intake Trends and Specialized Diets 
 Analyzing overall diet with reference to respiratory health is also a focus of 
asthma-related research. One cross-sectional study done by McKeever et al. (2010) 
looked at the dietary patterns and lung function of 12,648 adult participants in the 
Netherlands. Diets high in red meats, potato, boiled vegetables, added fat, coffee, and 
beer had a strong negative correlation with lung function tests and a strong positive 
correlation with prevalence of chronic obstructive pulmonary disease. These correlations 
were the most significant for high alcohol and added fat intake. Diets high in refined 
foods and low in fresh vegetables, fruit, and whole grains were also strongly linked with 
decline in lung function, though further research is needed before any claims of causation 
can be made. Also of note, this study found that diets high in vegetables, white meats, 
wine, and rice and low in dairy products had a small positive correlation between that diet 
and wheeze in asthmatic patients, with no significant decreases in lung function tests. 
This diet pattern was also identified as being rich in vitamin C and beta-carotene, while 
the other diets mentioned were low in vitamin C (McKeever et al., 2010).   
 Another cross-sectional study done by Rosenkranz, Rosenkranz, & Neessen 
(2012) looked at dietary trends, asthma diagnosis, and hay fever diagnosis in 156,035 
Australian participants. Of these participants, 12% had a diagnosis of asthma and 23% 
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had a dual diagnosis of both asthma and hay fever. For the male participants, diets high in 
red meats, cheeses, and white meats had a significant positive association with a 
diagnosis of asthma or a combined diagnosis of asthma and hay fever. For female 
participants, a similar relationship between meat intake and asthma diagnosis was 
detected, but results also showed that high intake of cheeses and carbohydrates had a 
negative correlation with these diagnoses. The findings of this study suggest a possible 
protective effect of carbohydrates and dairy products for women at risk for developing 
asthma, but the cross-sectional nature of this study limits inference of a cause-and-effect 
relationship (Rosenkranz, Rosenkranz, & Neessen, 2012). 
Specially designed diets like the Mediterranean diet and the Dietary Approaches 
to Stop Hypertension (DASH) may also help to improve asthma control and reduce 
symptoms when used in conjunction with standard medical treatment. These diets 
emphasize fresh fruits, fresh vegetables, whole grains, and fish while limiting overly 
processed, sodium-rich, and saturated fatty acid-rich foods. While these diets hold 
potential for improving asthma status, research into their implementation in the adult 
asthmatic patient population is either ongoing, as is the case for the DASH diet, or 
requires more extensive research before definitive guidelines can be reached for 
incorporating these diets into standard clinical practice for asthma management (Ma et 
al., 2013; Sexton et al., 2013).  
One randomized trial with 38 adult asthmatic participants examined the effects of 
adopting a Mediterranean diet on lung function, quality of life, and frequency of 
asthmatic symptoms. Participants in the high-intervention group received 41 hours of 
nutritional counseling, those in the low-intervention group received 2 hours of nutritional 
DIET AND ASTHMA  21 
counseling, and those in the control group received recipes and an offer for a single 
session with a dietician. All participants in the group were provided with food vouchers 
to facilitate access to foods in the Mediterranean diet and to reduce possible 
socioeconomic compounding factors. The high-intervention group reported greater 
adherence to the Mediterranean diet than the other groups, eating more fish and fruit and 
reducing intake of red meats and chicken than those in the low-intervention or control 
group, suggesting that frequent access to a dietician or equivalent healthcare resource 
improves a person’s likelihood of implementing long-term dietary changes. The high-
intervention group reported increased quality of life, but the results were not statistically 
significant, and there were no significant changes in lung function in any of the 
participant groups. The small sample size of this study may have limited its ability to 
obtain statistically significant results. An area for future research is to further examine 
how adhering to the Mediterranean diet may influence asthma in a more extensive group 
of participants (Sexton et al., 2013).  
Implementing Dietary Changes 
 Knowledge of dietary influences on patients with asthma may be helpful for 
managing asthma, but an understanding of what motivates a person to make life changes 
is also key to implementing effective dietary interventions. Financial stress and access to 
a limited range of food options may negatively influence food selection by discouraging 
healthy food choices (Nguyen, Shuval, Bertmann, & Yaroch, 2015). Insufficient 
understanding of nutrition, insufficient motivation, established eating habits, and 
convenience may also factor into poor decision making when it comes to food selection 
and asthma management (Calder, Davidson, & Ho, 2011). Patients also might not change 
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their dietary intake if they are unaware that certain changes might help to improve or 
control their condition, so it is important for healthcare providers to be familiar with and 
properly educate patients about relevant, accurate, and up to date information regarding 
all aspects of treatment (Argüder, Yilmaz, Ateş, Misirligil, & Bavbek, 2012; Kligler et 
al., 2011; Tapp et al., 2014; Zoellner, Van Horn, Gleason, & Boushey, 2015).  
The protection motivation theory and the ordered protection motivation theory 
both involve the ways that a person appraises the severity and likelihood of threats. These 
two theories emphasize that coping appraisal is more significant than threat appraisal in 
making dietary decisions. In other words, a person’s dietary decisions are influenced by 
that person’s self-identified ability to adapt and that person’s confidence in the 
effectiveness of a change. This means that a person’s dietary choices will improve if he 
or she feels capable of implementing change and if he or she is confident that the change 
will actually help reduce the threat. While identifying health threats is important, health 
education is most effective when the focus is on empowering and equipping people for 
change. Health promotion education materials should thus include health risks while 
focusing on how to implement dietary changes and how effective the change will be 
(Calder et al., 2011). 
Another important aspect of implementing dietary change is how well information 
translates from research into evidence-based practice in a clinical setting. If the 
healthcare team providing care to an asthma patient is unaware of or not implementing 
the latest advances in nutritional management of this condition, then the patient may not 
learn of or benefit from the potentially helpful interventions supported in the research 
literature. This omission could be especially impactful for asthma patients with poor 
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response to medications and other standard asthma interventions, as these patients might 
benefit from additional support measures to improve quality of life and symptom control 
(Argüder et al., 2012; Kligler et al., 2011; Tapp et al., 2014; Zoellner et al., 2015). 
Delays in applying conclusive results from sound research to actual clinical 
practice are common and can sometimes take over a decade before they benefit actual 
patients. The more efficiently research is translated into practice, the quicker it can 
improve patient care. There are multiple methods of trying to organize this translation 
process; these methods generally include a focus on identifying effective interventions, 
spreading accurate information about those interventions to the physicians, dieticians, and 
other care providers, and consistently evaluating implementation of research so that 
organizations can adapt methods and continuously improve patient care. When 
developing a new program based on research, one way to help improve effectiveness of 
the program is to involve the key stakeholders: the target patient population, the 
community, and health care providers from multiple disciplines (Argüder et al., 2012; 
Tapp et al., 2014; Zoellner et al., 2015).  
In situations involving complementary and alternative medicine (CAM), which 
can include nutrition changes, the level of familiarity and knowledge a care provider has 
with these interventions can influence patient education and implementation. A study 
done by Argüder et al. (2012) surveyed 242 physicians who worked with allergy and 
asthma patients. The survey asked about the physicians’ familiarity with CAM and how 
comfortable the physicians’ felt referring patients to CAM oriented treatments. The CAM 
referrals included nutrition referrals for asthma patients. This study found that more than 
half of the physicians surveyed reported having insufficient knowledge about CAM to 
DIET AND ASTHMA  24 
meet patient needs, despite having a desire to learn about CAM. The survey reports also 
found that physicians who felt prepared with adequate information were more likely to 
share this information with their patients, while those who felt unprepared were more 
likely to omit CAM referrals from day-to-day practice. While this study has a small 
sample size and non-experimental design, it provides an opening for questions about how 
to provide proper information to healthcare providers so that those providers can transmit 
that information to patients (Argüder et al., 2012). 
One ongoing study in North Carolina is looking at various ways to spread 
information about asthma treatment interventions to primary care clinics using Medicaid 
and existing research networks. The methods under examination include a method of 
once-yearly educational events for staff with handouts versus a more intensive method of 
12 consecutive weeks of one-hour training sessions for staff on how to use resources for 
asthma treatment. This study also has a control group of clinics with no specified changes 
in the method for providing information to staff. The research team conducting this study 
hypothesizes that the weekly program will be the most effective program at increasing 
shared-decision making, with medical staff facilitating involvement of patients in 
developing plans of care. Subsequently, the research team predicts that increasing patient 
involvement in health care decisions will improve asthma exacerbations and increase 
patient satisfaction with care. While conclusions cannot be drawn from this study until 
data collection and analysis is complete, this study is one example of current and future 
research trends into asthma management and working with patients to identify what they 
are willing to change in order to improve their condition (Tapp et al., 2014).  
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Method 
 Articles were included in the review if they had publishing dates between 2009 
and 2016. Articles published prior to 2009 were excluded unless they represented 
research that remains fundamental to the subject. Preference for inclusion in this review 
was given to quantitative research; however, applicable qualitative studies and clinical 
expertise were included. To be included in the review, articles had to be peer reviewed 
and the authors had to hold an advanced degree in the area of study. Articles were 
gathered using EBSCO host and related databases. Key search words included: asthma, 
diet, nutrition, inflammation, omega-3, omega-6, arachidonic acid, EPA, DHA, 
polyunsaturated fatty acids, fatty acids, linoleic acid, fish oil, antioxidants, and 
intervention.  
Summary 
 PUFA, vitamins, antioxidants, and total dietary patterns may influence respiratory 
health and symptoms in asthma patients. Although further research is needed, diets high 
in refined or processed foods tend to be associated with poor respiratory health while 
diets high in fresh fruit, fresh vegetables, whole grains, and fish tend to be associated 
with good respiratory health or improvement in respiratory health. The role of individual 
nutrients in respiratory health is not well defined and further research is required to 
establish clinical guidelines involving standardized doses, quantified therapeutic 
responses, and the impact of polymorphisms on patient response to various dietary 
supplementations.  
People are more likely to go through with dietary alterations if they perceive that 
they are capable of enacting change and that the change will be directly beneficial to 
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them, as opposed to if they simply perceive the risks of an unaltered diet. Also, since 
nutrients are generally not consumed in isolation from each other, total diet interventions 
are likely to be more effective at improving health than single nutrient interventions. 
Education on dietary change should focus on how to implement the new diet and what 
definitive improvements will result from the change. Though understanding the risks of 
certain diet patterns is important for patient motivation, patients are more likely to 
succeed at altering their diet if they feel competent and confident about the effectiveness 
of their changes.  
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